Oriola Oyj — Capital/Financing Update 2013

Jun 3, 2013

Oriola-KD's fully owned subsidiary Medstop AB will exercise the option to call the SEK 700 million bonds

Oriola-KD's fully owned subsidiary Medstop AB will exercise the option to call the SEK 700 million bonds

Oriola-KD Corporation Stock Exchange Release 3 June 2013 at 1.05 p.m

In connection with the completion of the Medstop acquisition Oriola-KD's fully
owned subsidiary Medstop AB will exercise the option to call all of the
outstanding SEK 700 million bonds (ISIN SE0003961655). The bonds will be called
pursuant to § 7 of the Terms and Conditions where Medstop will exercise its
right to call the bonds at 102.75 per cent of the Nominal Amount plus accrued
interest.

The redemption date of the bonds is 2 July 2013 and one must be a bondholder on
25 June 2013 to have a right to the payment. The bonds will cease to trade on
19 June 2013 and as part of the early redemption process the bonds will also be
de-listed from the Frankfurt Stock Exchange. The redemption of the bonds will be
financed by existing credit facilities.

Oriola-KD Corporation

Oriola-KD Corporation

Tuomas Itkonen
CFO

Joni Ihantola
Vice President, Treasury and IR

For further information, please contact:

Tuomas Itkonen
CFO
Tel. +358 (0)46 876 5207
e-mail: tuomas.itkonen@oriola-kd.com

Joni Ihantola
Vice President, Treasury and IR
tel. +358 (0)10 429 4386
email: joni.ihantola@oriola-kd.com

Distribution:
NASDAQ OMX Helsinki Ltd.
Key media

Released by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola-kd.com

[HUG#1706581]